Provided by Tiger Trade Technology Pte. Ltd.

4D Molecular Therapeutics

9.66
0.0000
Post-market: 9.660.00000.00%19:18 EST
Volume:744.12K
Turnover:7.12M
Market Cap:492.74M
PE:-2.58
High:9.72
Open:9.60
Low:9.38
Close:9.66
52wk High:12.34
52wk Low:2.24
Shares:51.01M
Float Shares:36.78M
Volume Ratio:1.04
T/O Rate:2.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7446
EPS(LYR):-2.9821
ROE:-45.38%
ROA:-27.64%
PB:1.34
PE(LYR):-3.24

Loading ...

May 08, 2025

Major Issues Report

Form 8-K - Current report
Feb 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2025

Major Issues Report

Form 8-K - Current report
Feb 10, 2025

Major Issues Report

Form 8-K - Current report
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 18, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Jul 23, 2024

Major Issues Report

Form 8-K - Current report
Jul 17, 2024

Major Issues Report

Form 8-K - Current report
Jul 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities